Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease

Neuroreport. 2001 Dec 21;12(18):3969-72. doi: 10.1097/00001756-200112210-00023.

Abstract

Cell-cycle dysregulation might be critically involved in the process of neurodegeneration in Alzheimer's disease (AD). We now provide evidence for a dysfunction of the cell division cycle as a more general cellular phenomenon of the disease. Peripheral blood lymphocytes, stimulated with mitogenic compounds, were less able to express CD69, an early proliferation marker, in AD patients than in age-matched controls. Expression levels of CD69 of both T-cells and B-cells correlated inversely with the Mini-mental Scale. The results suggest that a systemic failure of cellular proliferation control might be of critical importance for the pathomechanism of AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics
  • Alzheimer Disease / immunology*
  • Alzheimer Disease / pathology*
  • Antigens, CD / biosynthesis
  • Antigens, Differentiation, T-Lymphocyte / biosynthesis
  • Apolipoproteins E / genetics
  • B-Lymphocytes / cytology*
  • B-Lymphocytes / drug effects
  • Cell Division / drug effects
  • Cell Division / immunology
  • Flow Cytometry
  • Genotype
  • Humans
  • Lectins, C-Type
  • Mitogens / pharmacology
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / drug effects

Substances

  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • Apolipoproteins E
  • CD69 antigen
  • Lectins, C-Type
  • Mitogens